The death toll from the Marburg virus in Rwanda has risen to 11 after one more fatality was recorded on Wednesday, October 2. This was confirmed by the Ministry of Health, which also reported seven new cases, bringing the total number of confirmed cases to 36.
Currently, 25 individuals remain under isolation and treatment, as health authorities continue their efforts to contain the spread of the virus. Rwanda confirmed its first outbreak of the deadly Marburg virus on September 27, marking a significant public health challenge for the country.
The Ministry of Health has identified around 300 individuals as contacts of confirmed cases, all of whom are under close monitoring. Health officials are working diligently to track and contain the virus, which is known for its high fatality rate and contagious nature.
In response to the rising cases, the Ministry of Health has implemented new measures designed to prevent further infections. These guidelines, issued on Sunday, include a 14-day suspension of hospital visits and the reinforcement of strict hygiene practices. Citizens are advised to limit contact with individuals displaying symptoms such as fever, headaches, and muscle pain—common indicators of the haemorrhagic disease.
While business activities will remain open, the public is strongly urged to adhere to hygiene protocols, including frequent handwashing, especially in public spaces.
The Ministry of Education has also introduced preventive guidelines to protect students, particularly those in boarding schools. As part of these measures, monthly visits to boarding school students have been suspended to reduce the risk of transmission within educational institutions.
Rwanda’s health authorities are urging the public to remain vigilant and cooperate with preventive measures. The Marburg virus, a highly contagious disease transmitted through direct contact with the bodily fluids of infected individuals, poses a significant threat. Anyone exhibiting symptoms is encouraged to seek immediate medical assistance by calling the national toll-free hotline, 114.
